Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pelmeg 6mg/0.6ml solution for injection pre-filled syringes
0901060P0BDAAAA
|
Pelmeg | Pegfilgrastim | Nutrition and Blood | No data available |
|
Pembrolizumab 100mg/4ml solution for infusion vials
0801050CAAAABAB
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pembrolizumab 50mg powder for solution for infusion vials
0801050CAAAAAAA
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pemetrexed 100mg powder for solution for infusion vials
0801030Y0AAABAB
|
Pemetrexed | Pemetrexed | Malignant Disease and Immunosuppression | No data available |
|
Pemetrexed 500mg powder for solution for infusion vials
0801030Y0AAAAAA
|
Pemetrexed | Pemetrexed | Malignant Disease and Immunosuppression | No data available |
|
Penbritin 125mg/5ml syrup
0501013E0BEADAE
|
Penbritin | Ampicillin | Infections | No data available |
|
Penbritin 250mg capsules
0501013E0BEAAAA
|
Penbritin | Ampicillin | Infections | No data available |
|
Penbritin 500mg capsules
0501013E0BEABAB
|
Penbritin | Ampicillin | Infections | No data available |
|
Penbritin 500mg powder for solution for injection vials
0501013E0BEAHAD
|
Penbritin | Ampicillin | Infections | No data available |
|
Penbritin Forte 250mg/5ml syrup
0501013E0BEAEAF
|
Penbritin | Ampicillin | Infections | No data available |
|
Penicillamine 125mg/5ml oral solution
1001030F0AAAJAJ
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine 250mg/5ml oral solution
1001030F0AAAIAI
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine 250mg/5ml oral suspension
1001030F0AAALAL
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine 50mg/5ml oral solution
1001030F0AAAKAK
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine gastro-resistant 150mg tablets
1001030F0AAAMAM
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penicillamine gastro-resistant 300mg tablets
1001030F0AAANAN
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | No data available |
|
Penile sheath 20mm
22300503005
|
Penile sheath 20mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Penile sheath 25mm
22300503006
|
Penile sheath 25mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Penile sheath 30mm
22300503007
|
Penile sheath 30mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Penile sheath 35mm
22300503008
|
Penile sheath 35mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Penile sheath 40mm
22300503009
|
Penile sheath 40mm | Incontinence Sheaths | Incontinence Appliances | No data available |
|
Pennsaid 16mg/ml cutaneous solution
1003020U0BEAAAD
|
Pennsaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Pentacarinat 300mg powder for solution for injection vials
0504080P0BBAAAA
|
Pentacarinat | Pentamidine isetionate | Infections | No data available |
|
Pentacarinat Ready-to-Use 300mg/5ml nebuliser liquid
0504080P0BBABAB
|
Pentacarinat | Pentamidine isetionate | Infections | No data available |
|
Pentagastrin 500micrograms/2ml inj ampoules
180400000AABABA
|
Generic compound preparation BNF 1804000 | Other diagnostic agent preparations | Preparations used in Diagnosis | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.